Terms: = Leukemia AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
238 results:
1. Network pharmacology-based investigation and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia.
Liu S; Xu M; Yang Z; Li Y; Wu D; Tang X
Eur J Med Res; 2024 Sep; 29(1):475. PubMed ID: 39343915
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant HIF1- α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid leukemia Patients with Isocitrate Dehydrogenase 1 Mutations.
Ali T; Usman R; Shah SA; Parvez A; Anwar S; Muneer Z; Saeed M
Cancer Control; 2024; 31():10732748241271714. PubMed ID: 39110525
[TBL] [Abstract] [Full Text] [Related]
3. The Role of PTEN in Chemoresistance Mediated by the HIF-1α/YY1 Axis in Pediatric Acute Lymphoblastic leukemia.
Antonio-Andres G; Morales-Martinez M; Jimenez-Hernandez E; Huerta-Yepez S
Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063014
[TBL] [Abstract] [Full Text] [Related]
4. Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment.
Romero-Trejo D; Aguiñiga-Sanchez I; Ledesma-Martínez E; Weiss-Steider B; Sierra-Mondragón E; Santiago-Osorio E
Med Oncol; 2024 Jul; 41(8):200. PubMed ID: 38990440
[TBL] [Abstract] [Full Text] [Related]
5. Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells.
Donnelly H; Ross E; Xiao Y; Hermantara R; Taqi AF; Doherty-Boyd WS; Cassels J; Tsimbouri PM; Dunn KM; Hay J; Cheng A; Meek RMD; Jain N; West C; Wheadon H; Michie AM; Peault B; West AG; Salmeron-Sanchez M; Dalby MJ
Nat Commun; 2024 Jul; 15(1):5791. PubMed ID: 38987295
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic dysregulation in cancers by isocitrate dehydrogenase 2 (IDH2).
Nayarisseri A; Bandaru S; Khan A; Sharma K; Bhrdwaj A; Kaur M; Ghosh D; Chopra I; Panicker A; Kumar A; Saravanan P; Belapurkar P; Mendonça Junior FJB; Singh SK
Adv Protein Chem Struct Biol; 2024; 141():223-253. PubMed ID: 38960475
[TBL] [Abstract] [Full Text] [Related]
7. Placental apoptosis increased by hypoxia inducible factor-1 stabilization is counteracted by leptin†.
de Dios N; Riedel R; Schanton M; Balestrini P; Pérez L; Pérez-Pérez A; Etcheverry T; Casale R; Farina M; Sánchez-Margalet V; Maymó J; Varone C
Biol Reprod; 2024 Sep; 111(3):708-722. PubMed ID: 38924703
[TBL] [Abstract] [Full Text] [Related]
8. Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations.
Tawfik HO; Mousa MHA; Zaky MY; El-Dessouki AM; Sharaky M; Abdullah O; El-Hamamsy MH; Al-Karmalawy AA
Bioorg Chem; 2024 Aug; 149():107483. PubMed ID: 38805913
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in leukemia.
Pandey S; Singh R; Habib N; Tripathi RM; Kushwaha R; Mahdi AA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1121-1134. PubMed ID: 38679971
[TBL] [Abstract] [Full Text] [Related]
10. [Effects of BMAL2 on Aerobic Glycolysis and Cell Proliferation in Acute Myeloid leukemia Cells].
Jia WJ; Mu J; Cui WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):402-408. PubMed ID: 38660843
[TBL] [Abstract] [Full Text] [Related]
11. The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.
Lawson H; Holt-Martyn JP; Dembitz V; Kabayama Y; Wang LM; Bellani A; Atwal S; Saffoon N; Durko J; van de Lagemaat LN; De Pace AL; Tumber A; Corner T; Salah E; Arndt C; Brewitz L; Bowen M; Dubusse L; George D; Allen L; Guitart AV; Fung TK; So CWE; Schwaller J; Gallipoli P; O'Carroll D; Schofield CJ; Kranc KR
Nat Cancer; 2024 Jun; 5(6):916-937. PubMed ID: 38637657
[TBL] [Abstract] [Full Text] [Related]
12. PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral Cancer Cells.
Yadav AK; Wang S; Shin YM; Jang BC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474118
[TBL] [Abstract] [Full Text] [Related]
13. HIF-1α/m
Cong X; Li X; Xu K; Yin L; Liang G; Sun R; Pu Y; Zhang J
Environ Int; 2024 Feb; 184():108493. PubMed ID: 38350257
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic drug screening for trophoblast syncytialization reveals a novel role for MLL1 in regulating fetoplacental growth.
Wu J; Qin C; Tian F; Liu X; Hu J; Wu F; Chen C; Lin Y
BMC Med; 2024 Feb; 22(1):57. PubMed ID: 38317232
[TBL] [Abstract] [Full Text] [Related]
15. New genetic drivers in hemorrhagic hereditary telangiectasia.
Cerdà P; Castillo SD; Aguilera C; Iriarte A; Rocamora JL; Larrinaga AM; Viñals F; Graupera M; Riera-Mestre A
Eur J Intern Med; 2024 Jan; 119():99-108. PubMed ID: 37689549
[TBL] [Abstract] [Full Text] [Related]
16. Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells.
Vogiatzoglou AP; Spanou S; Sachini N; Drakos E; Nikolaou C; Makatounakis T; Kretsovali A; Papamatheakis J
Mol Oncol; 2023 Oct; 17(10):2090-2108. PubMed ID: 37518985
[TBL] [Abstract] [Full Text] [Related]
17. Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid leukemia Based on Integrating Network Pharmacology and Molecular Docking.
Li HX; Jing YX; Chai YH; Sun XH; He XX; Xue SL; Xi YM; Ma XL
Anticancer Agents Med Chem; 2023; 23(16):1838-1847. PubMed ID: 37246327
[TBL] [Abstract] [Full Text] [Related]
18. Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia.
Gayatri MB; Kancha RK; Patchva D; Velugonda N; Gundeti S; Reddy ABM
FEBS J; 2023 Sep; 290(18):4480-4495. PubMed ID: 37171230
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.
Wang X; Chen C; Vuong D; Rodriguez-Rodriguez S; Lam V; Roleder C; Wang JH; Thiruvengadam SK; Berger A; Pennock N; Torka P; Hernandez-Ilizaliturri F; Siddiqi T; Wang L; Xia Z; Danilov AV
Leukemia; 2023 Jun; 37(6):1324-1335. PubMed ID: 37031300
[TBL] [Abstract] [Full Text] [Related]
20. Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca 2+ -dependent gap junction intercellular communication.
Li X; Xiao Y; Wang X; Huang R; Wang R; Deng Y; Rao J; Gao Q; Yang S; Zhang X
Chin Med J (Engl); 2023 Jan; 136(2):194-206. PubMed ID: 36801891
[TBL] [Abstract] [Full Text] [Related]
[Next]